2017 International Congress Archives - Page 72 of 155

2017 International Congress

June 4-8, 2017. Vancouver, BC.

How do Parkinson’s Disease patients manage Ramadan Fasting?

W. Kamel, P. Damier, J. Al-Hashel (Kuwait, Kuwait)
How efficient is subthalamic deep brain stimulation in reducing dyskinesia in Parkinson’s Disease?

N. Kovacs, A. Juhász, I. Balás (Pecs, Hungary)
How to switch from Entacapone to Opicapone based on BIPARK-I study experience

J. Ferreira, A. Lees, A. Santos, B. Hernandez, F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
How Usual Is Skin Rashes During Treatment With Levodopa / Benserazide Hydrochloride?

E. Okuyucu, M. Uzel, S. Colakoglu Yesıldag, M. Guntel (Hatay, Turkey)
How will new technology change deep brain stimulation programming?

G. Duffley, A. Schiewe, B. Lutz, J. Krüger, M. Okun (Salt Lake City, UT, USA)
Hung up knee jerk reflex in Huntington’s disease: A clinical and neurophysiological study

J. Perez-Perez, J. Diaz-Manera, J. Pagonabarraga, S. Martinez-Horta, M. Carceller, A. Horta, J. Marin, H. Bejr-Kasen, A. Guerrero, J. Kulisevsky (Barcelona, Spain)
Huntington’s disease in the Republic of Tatarstan, epidemiological features

S. Munasipova, Z. Zalyalova (Kazan, Russian Federation)
Huntington’s Disease Regulatory Science Consortium (HD-RSC): Enabling Pathways to Effective Treatments Through Regulatory Science and Innovation

C. Fitzer-Attas, D. Stephenson, K. Romero, J. Neville, C. Sampaio (Critical Path Institute, Tucson, AZ; CHDI Foundation, Princeton, NJ)
Huntington’s Disease: Determinants for Cognitive Disease Progression – A Proposed Model

N. Gonçalves, J. Mendes, J. Ferreira, C. Sampaio (Lisbon, Portugal)
Hypertension and Parkinson’s disease

B. Giordano, G. Pagano, J. Hood, N. Ferrara, M. Politis (London, United Kingdom)